Analystreport

Emergent Biosolutions Inc (NYSE: EBS) had its price target raised by analysts at Guggenheim from $81.00 to $101.00.

Emergent Biosolutions, Inc.  (EBS) 
Last emergent biosolutions, inc. earnings: 4/30 04:08 pm Check Earnings Report
US:NYSE Investor Relations: investors.emergentbiosolutions.com